跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
ENRYLAZE 10 MG/0,5 ML, SOLUCION INYECTABLE Y PARA PERFUSION - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
ENRYLAZE 10 MG/0,5 ML, SOLUCION INYECTABLE Y PARA PERFUSION
Approved
STANDARD
ENRYLAZE 10 MG/0,5 ML, SOLUCION INYECTABLE Y PARA PERFUSION
Jazz Pharmaceuticals Ireland Limited
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 13, 2024
Approval ID
24239b488359c9df
Company
Jazz Pharmaceuticals Ireland Limited
Type
Standard
Approval Details
Approval Id
24239b488359c9df
Drug Cima Aemps Name
ENRYLAZE 10 MG/0,5 ML, SOLUCION INYECTABLE Y PARA PERFUSION
Register Number
1231747001
Holder Company Name
Jazz Pharmaceuticals Ireland Limited
Marketing Company Name
Jazz Pharmaceuticals Iberia S.L.
Holder Company Detail Path
/organization/jazz-pharmaceuticals-ireland-limited
Authorization Date
2024-02-13
Dosage Form
SOLUCIÓN INYECTABLE Y PARA PERFUSIÓN
Dose
10 mg
Route Of Administration
VÍA INTRAMUSCULAR, VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Jazz Pharmaceuticals Ireland Limited
Company Detail Path
/organization/jazz-pharmaceuticals-ireland-limited
Company Information
Pharmaceutical Company Name
JAZZ PHARMACEUTICALS IRELAND LIMITED
Country Name
Ireland
City Name
dublin,country_ie
Address
5th Floor Waterloo Exchange
Active Ingredients
CRISANTASPASA
10 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 13, 2024
Approval ID
24239b488359c9df
Type
Standard
Back to CIMA-AEMPS Approvals